What is a growth hormone secretagogue?

A compound described in the literature as stimulating the release of growth hormone, rather than being growth hormone itself. The term covers several structurally unrelated groups.

What is the difference between a GHRH analog and a ghrelin receptor agonist?

They are described as acting on different receptors. GHRH analogs resemble growth hormone releasing hormone; ghrelin receptor agonists are structurally unrelated and act at a different site.

Which compounds in this class does Evra supply?

CJC-1295 with DAC, sermorelin and tesamorelin as GHRH analogs; ipamorelin as a ghrelin receptor agonist. The Growth Hormone Stack bundles CJC-1295 with ipamorelin.

Back to guides

Compound class

Growth hormone secretagogues explained

A class label covering several unrelated groups. Here is what separates them and which compounds belong where.

“Growth hormone secretagogue” is a class label, not a single compound. It covers several structurally unrelated groups that the literature describes as acting on the same signalling system through different receptors.

The two groups we stock

GHRH analogs

Molecules resembling growth hormone releasing hormone, a 44 amino acid peptide. Variants differ in which part of the sequence they reproduce and what modifications they carry to resist enzymatic breakdown.

Sermorelin: GHRH(1–29), the native active fragment
Tesamorelin: a stabilised analog
CJC-1295 with DAC: albumin-binding modification, extended half-life

Ghrelin receptor agonists

Structurally unrelated to GHRH, described as acting at the ghrelin receptor.

Ipamorelin: a pentapeptide described as selective at this receptor

Side by side

Compound	Group	Structure	Vial	Price
Sermorelin	GHRH analog	GHRH(1–29)	10mg	$200
Tesamorelin	GHRH analog	Stabilised analog	10mg	$150
CJC-1295 w/ DAC	GHRH analog	Albumin-binding (DAC)	10mg	$150
Ipamorelin	Ghrelin receptor agonist	Pentapeptide	10mg	$100

Why the distinction matters

Because compounds within a class are not interchangeable. A GHRH analog and a ghrelin receptor agonist are described as acting at different sites, and two GHRH analogs differ in structure and stability. Grouping compounds by class is useful for understanding the literature, not for treating them as substitutes.

Common questions

What is a growth hormone secretagogue?: A compound described in the literature as stimulating the release of growth hormone, rather than being growth hormone itself. The term covers several structurally unrelated groups.
What is the difference between a GHRH analog and a ghrelin receptor agonist?: They are described as acting on different receptors. GHRH analogs resemble growth hormone releasing hormone; ghrelin receptor agonists are structurally unrelated and act at a different site.
Which compounds in this class does Evra supply?: CJC-1295 with DAC, sermorelin and tesamorelin as GHRH analogs; ipamorelin as a ghrelin receptor agonist. The Growth Hormone Stack bundles CJC-1295 with ipamorelin.

Still stuck?

Message the team on Telegram and we will sort it out, usually within minutes.

Message the team on Telegram

Available individually or bundled

10mg vials, Australian stock, 24 hour dispatch.

Shop peptides

For research use only. This page describes what these compounds are and what published research has investigated. It does not recommend one over another, does not describe any effect in humans, and is not medical advice or a dosing recommendation. Evra Peptides products are supplied strictly for laboratory research and are not for human or veterinary consumption, nor for diagnostic or therapeutic use. You must be 18 or over to order.